PLX4720

  • 1 lab in 1 country
  • Funders: Cancerfonden and 2 more
  • Animals1

Outcomes

1

Tumor growth

downin mice1

1 study
  1. PLX4720 inhibits tumor growth in mice.

    “Oral treatment of mutant mice for 1 month with PLX4720, a vemurafenib prodrug, partially reduced cytokine expression along with inhibited tumor growth and redifferentiation of thyroid function.”

    Animalsthyroid1 month

    Heterogeneous pro-inflammatory response to BRAFV600E-induced thyroid tumor development

    bioRxiv (Cold Spring Harbor Laboratory)29 Mar 2026Preprint

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months